Keryx Biopharmaceuticals Inc Watch

from SC 13D/A 1 page Joint Filing Agreement

from S-3 44 pages Keryx Biopharmaceuticals, Inc. Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement

from SC 13D 1 page Joint Filing Agreement

from 8-K 41 pages Keryx Biopharmaceuticals, Inc. 9,166,667 Shares Common Stock ($0.001 Par Value) Underwriting Agreement

from 8-K 42 pages Keryx Biopharmaceuticals, Inc. 6,900,000 Shares Common Stock ($0.001 Par Value) Underwriting Agreement

from 8-K 41 pages Keryx Biopharmaceuticals, Inc. 8,234,000 Shares Common Stock ($0.001 Par Value) Underwriting Agreement

from 8-K 2 pages We Are Acting as Counsel to Keryx Biopharmaceuticals, Inc., a Delaware Corporation (The “Company”) in Connection With the Registration Statement on Form S-3 (File No. 333-171517) Filed by the Company With the Securities and Exchange Commission (The “Commission”) Pursuant to the Securities Act of 1933, as Amended (The “Securities Act”), on January 3, 2011 (The “Registration Statement”) and Declared Effective by the Commission on January 28, 2011, and the Issuance and Sale of an Aggregate of 7,021,277 Shares (The “Shares”) of Common Stock, Par Value $0.001 Per Share, of the Company (The “Common Stock”) Off of the Registration Statement. the Company Is Selling the Shares to Stifel, Nicolaus & Company, Incorporated, Oppenheimer & Co. Inc., Roth Capital Partners, LLC, Rodman & Renshaw, LLC, Brean Murray, Carret & Co., LLC and Ladenburg Thalmann & Co. Inc.(the “Underwriters”) Pursuant to the Underwriting Agreement Dated May 4, 2011 (The “Underwriting Agreement”) Between the Company and the Underwriters. This Opinion Is Furnished to You at Your Request in Accordance With the Requirements of Item 16 of the Commission’s Form S-3 and Item 601(b)(5) of Regulation S-K Promulgated Under the Securities Act

from 8-K 38 pages Keryx Biopharmaceuticals, Inc. 7,021,277 Shares Common Stock ($0.001 Par Value) Underwriting Agreement

from 8-K 17 pages Underwriting agreement

from 8-K 31 pages Securities Purchase Agreement

from 8-K 8 pages Securities Purchase Agreement

from 8-K ~50 pages Underwriting Agreement

from 10-Q ~50 pages U.S. and Int'l Underwriting Agreement

from S-1/A ~20 pages Nominated Advisor Agreement

from S-1/A ~10 pages Nominated Broker Agreement

from S-1/A ~50 pages Underwriting agreement